Antiemesis: Clinical practice guidelines in Oncology™

David S. Ettinger; Philip J. Bierman; Bob Bradbury; Carli C. Comish; Georgiana Ellis; Robert J. Ignoffo; Steve Kirkegaard; Dwight D. Kloth; Mark G. Kris; Dean Lim; Michael Anne Markiewicz; Robert McNulty; Lidia Nabati; Barbara Todaro; Susan Urba; Sally Yowell

Antiemesis: Clinical practice guidelines in Oncology™

David S. Ettinger, Philip J. Bierman, Bob Bradbury, Carli C. Comish, Georgiana Ellis, Robert J. Ignoffo, Steve Kirkegaard, Dwight D. Kloth, Mark G. Kris, Dean Lim, Michael Anne Markiewicz, Robert McNulty, Lidia Nabati, Barbara Todaro, Susan Urba, Sally Yowell

Research output: Contribution to journal › Article › peer-review

Abstract

Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.

Original language	English (US)
Pages (from-to)	12-33
Number of pages	22
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	5
Issue number	1
State	Published - Jan 1 2007
Externally published	Yes

Keywords

5-HT3 receptor antagonists
Anticipatory emesis
Antiemesis
Aprepitant
Chemotherapy-induced emesis
NCCN Clinical Practice Guidelines
NK-1-receptor antagonists
Nausea and vomiting
Palonosetron
Radiation-induced emesis

ASJC Scopus subject areas

Oncology

Access to Document

Fingerprint Dive into the research topics of 'Antiemesis: Clinical practice guidelines in Oncology™'. Together they form a unique fingerprint.

Cite this

Antiemesis : Clinical practice guidelines in Oncology™. / Ettinger, David S.; Bierman, Philip J.; Bradbury, Bob; Comish, Carli C.; Ellis, Georgiana; Ignoffo, Robert J.; Kirkegaard, Steve; Kloth, Dwight D.; Kris, Mark G.; Lim, Dean; Markiewicz, Michael Anne; McNulty, Robert; Nabati, Lidia; Todaro, Barbara; Urba, Susan; Yowell, Sally.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 5, No. 1, 01.01.2007, p. 12-33.

Research output: Contribution to journal › Article › peer-review

Ettinger, David S. ; Bierman, Philip J. ; Bradbury, Bob ; Comish, Carli C. ; Ellis, Georgiana ; Ignoffo, Robert J. ; Kirkegaard, Steve ; Kloth, Dwight D. ; Kris, Mark G. ; Lim, Dean ; Markiewicz, Michael Anne ; McNulty, Robert ; Nabati, Lidia ; Todaro, Barbara ; Urba, Susan ; Yowell, Sally. / Antiemesis : Clinical practice guidelines in Oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2007 ; Vol. 5, No. 1. pp. 12-33.

@article{ce3b29ab8427458ab9fcd7ba3a5f9b9a,

title = "Antiemesis: Clinical practice guidelines in Oncology{\texttrademark}",

abstract = "Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.",

keywords = "5-HT3 receptor antagonists, Anticipatory emesis, Antiemesis, Aprepitant, Chemotherapy-induced emesis, NCCN Clinical Practice Guidelines, NK-1-receptor antagonists, Nausea and vomiting, Palonosetron, Radiation-induced emesis",

author = "Ettinger, {David S.} and Bierman, {Philip J.} and Bob Bradbury and Comish, {Carli C.} and Georgiana Ellis and Ignoffo, {Robert J.} and Steve Kirkegaard and Kloth, {Dwight D.} and Kris, {Mark G.} and Dean Lim and Markiewicz, {Michael Anne} and Robert McNulty and Lidia Nabati and Barbara Todaro and Susan Urba and Sally Yowell",

year = "2007",

month = jan,

day = "1",

language = "English (US)",

volume = "5",

pages = "12--33",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "1",

}

TY - JOUR

T1 - Antiemesis

T2 - Clinical practice guidelines in Oncology™

AU - Ettinger, David S.

AU - Bierman, Philip J.

AU - Bradbury, Bob

AU - Comish, Carli C.

AU - Ellis, Georgiana

AU - Ignoffo, Robert J.

AU - Kirkegaard, Steve

AU - Kloth, Dwight D.

AU - Kris, Mark G.

AU - Lim, Dean

AU - Markiewicz, Michael Anne

AU - McNulty, Robert

AU - Nabati, Lidia

AU - Todaro, Barbara

AU - Urba, Susan

AU - Yowell, Sally

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.

AB - Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.

KW - 5-HT3 receptor antagonists

KW - Anticipatory emesis

KW - Antiemesis

KW - Aprepitant

KW - Chemotherapy-induced emesis

KW - NCCN Clinical Practice Guidelines

KW - NK-1-receptor antagonists

KW - Nausea and vomiting

KW - Palonosetron

KW - Radiation-induced emesis

UR - http://www.scopus.com/inward/record.url?scp=33846786930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846786930&partnerID=8YFLogxK

M3 - Article

C2 - 17239323

AN - SCOPUS:33846786930

VL - 5

SP - 12

EP - 33

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 1

ER -